These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27904011)

  • 1. [Build a medical plants production system by the industry-academia-government collaboration consortium].
    Goto K
    Nihon Yakurigaku Zasshi; 2016; 148(6):315-321. PubMed ID: 27904011
    [No Abstract]   [Full Text] [Related]  

  • 2. Open for collaboration: an academic platform for drug discovery and development at SciLifeLab.
    Arvidsson PI; Sandberg K; Forsberg-Nilsson K
    Drug Discov Today; 2016 Oct; 21(10):1690-1698. PubMed ID: 27373760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Industry-government - academia cooperation center for medical innovation in Hokkaido University].
    Kodama KB; Arato T
    Nihon Yakurigaku Zasshi; 2015 Nov; 146(5):268-74. PubMed ID: 26558312
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives on collaboration and infrastructure development among government, academia, and industry.
    O'Flaherty EJ
    Toxicol Lett; 1995 Sep; 79(1-3):297-8. PubMed ID: 7570669
    [No Abstract]   [Full Text] [Related]  

  • 5. Academia-industry Cooperation in the Medical Field: Matching Opportunities in Japan.
    Tsuruya N; Kawashima T; Shiozuka M; Nakanishi Y; Sugiyama D
    Clin Ther; 2018 Nov; 40(11):1807-1812. PubMed ID: 30415863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIEHS perspectives on collaboration among government, academia, and industry.
    Olden K
    Toxicol Lett; 1995 Sep; 79(1-3):287-9. PubMed ID: 7570666
    [No Abstract]   [Full Text] [Related]  

  • 7. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
    Litten RZ; Ryan M; Falk D; Fertig J
    Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthened ties between industry and academia are historical, productive, and crucial.
    Haller JA
    Surv Ophthalmol; 2014; 59(3):348-53. PubMed ID: 24656436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?
    Kaski JC
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):187-8. PubMed ID: 21503624
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical issues for effective collaboration between academia and industry in the field of regenerative medicine in Japan.
    Tsubouchi M; Morishita R; Tabata Y; Matsui S; Kawakami K
    Regen Med; 2008 Jul; 3(4):497-504. PubMed ID: 18588472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery dilemma and Cura quartet collaboration.
    Shah S; Federoff HJ
    Drug Discov Today; 2009 Nov; 14(21-22):1006-10. PubMed ID: 19815089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collaboration between academia and companies].
    Ueda M
    Nihon Rinsho; 2008 May; 66(5):997-1002. PubMed ID: 18464523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Transporter Consortium: a collaborative group of scientists from academia, industry, and the FDA.
    Huang SM; Zhang L; Giacomini KM
    Clin Pharmacol Ther; 2010 Jan; 87(1):32-6. PubMed ID: 20019700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
    Janero DR
    Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. University - industry collaborations: models, drivers and cultures.
    Ehrismann D; Patel D
    Swiss Med Wkly; 2015; 145():w14086. PubMed ID: 25658854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborating with academia: what you need to know.
    Dinunzio MC; Wilson AE; Pokotilow SB
    J Biomol Screen; 2002 Aug; 7(4):391-3. PubMed ID: 12230894
    [No Abstract]   [Full Text] [Related]  

  • 18. Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.
    Buck E; Mulvihill M; Iwata KK
    Mt Sinai J Med; 2010; 77(4):358-65. PubMed ID: 20687181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jumping the industrial-academia fence.
    Pollastri M
    Future Med Chem; 2013 Jan; 5(1):25-6. PubMed ID: 23256810
    [No Abstract]   [Full Text] [Related]  

  • 20. PROBLEMS OF DRUG DEVELOPMENT. THE GOVERNMENT, THE DRUG INDUSTRY, THE UNIVERSITIES, AND THE MEDICAL PROFESSION: PARTNERS OR ENEMIES?
    LASAGNA L
    Science; 1964 Jul; 145(3630):362-7. PubMed ID: 14175104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.